Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion type Assertion NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_head.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion wasGeneratedBy ECO_0000203 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion wasDerivedFrom befree-20140225 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion SIO_000772 21830945 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion evidence source_evidence_literature NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion description "[Intravitreal ranibizumab, which neutralizes vascular endothelial growth factor (VEGF), nowadays constitutes the first-line treatment in neovascular age-related macular degeneration (AMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.